Shaheen Majeed, global CEO & MD, Sami-Sabinsa Group elected as vice chairman, CII National Committee on IPR: Our Bureau, ...

Our Bureau, Mumbai Friday, October 18, 2024, 17:45 Hrs [IST] ...

HaystackAnalytics with its infexn NGS diagnostic test has successfully diagnosed a rare infection, known as Murine Typhus caused by an intracellular bacteria or Rickettsia typhi transmitted by fleas.

Viatris enters licensing agreement with Lexicon Pharma for sotagliflozin in all markets outside of the US & Europe: Pittsburgh Friday, October 18, 2024, 16:00 Hrs [IST] Viatris In ...

Delhi HC reinstates injunction on Zydus, halting sale of breast cancer drug Sigrima: Shardul Nautiyal, Mumbai Friday, October 18, 2024, 18:15 Hrs [IST] In another significant setb ...

Jaguar Health, Inc. announced that Jaguar family company Napo Pharmaceuticals (Napo) has initiated the commercial launch of the FDA-approved oral mucositis prescription product Gelclair in the US.

A National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents found it was safe and generated an antibody response equivalent to that seen in adults, according to a ...

UK MHRA grants marketing authorisation to AstraZeneca’s eplontersen to treat adults with rare inherited nerve disease or polyneuropathy: United Kingdom Friday, October 18, 2024, ...

Skinnovation introduces MCT & MIRApeel, two cutting edge revolutionary devices to address skin concerns in India: Our Bureau, Mumbai Friday, October 18, 2024, 14:15 Hrs [IST] Skin ...

NIH-funded study shows kidney transplantation between donors and recipients with HIV is safe: Bethesda, Maryland 20 Friday, October 18, 2024, 15:00 Hrs [IST] Kidney transplantatio ...

Eisai to request reconsideration of initial decision for lecanemab in Australia: Tokyo Friday, October 18, 2024, 12:00 Hrs [IST] Eisai Co., Ltd. and Biogen Inc. announced that the ...

Bayer to present latest research on impact and burden of menopause symptoms at IMS 2024: Berlin Friday, October 18, 2024, 11:00 Hrs [IST] Bayer will present latest research result ...